Brainomix AI lends weight to Endeavor Bio's IPF trial data
An AI-based imaging tool from Brainomix has been used to enrich data from a phase 2a trial of Endeavor's idiopathic pulmonary fibrosis drug taladegib.
Newsletters and Deep Dive digital magazine
An AI-based imaging tool from Brainomix has been used to enrich data from a phase 2a trial of Endeavor's idiopathic pulmonary fibrosis drug taladegib.
With AI, trial sponsors are now reducing risk, accelerating timelines, and driving innovation by modelling what is most likely to work in the future.
How can pharma lead the way in ethical AI and trust-driven innovation?
As investors place increasing emphasis on operational maturity alongside scientific excellence, cyber resilience must become part of the conversation.
Denmark's Netcompany has been awarded a five-year, £215m contract from NHS England to build the digital infrastructure for adult screening programmes.
Editor's Picks
Newsletters and Deep Dive
digital magazine